PKI - As demand surges at-home COVID test makers rise led by Cue Health and Lucira Health

The extremely high demand for at-home COVID-19 tests in the face of the rising number of cases is causing a spike in the share price of some test makers. Cue Health (HLTH +12.3%), Lucira Health (LHDX +13.6%), and Fulgent Genetics (FLGT +4.8%) are the three with the biggest gains today. Quidel (QDEL -1.8%), one of the largest makers of at-home tests, is an outlier in the group. Abbott Laboratories (ABT +0.2%), Becton, Dickinson (BDX +0.3%), OraSure (OSUR +0.2%), Danaher (DHR +1.1%), and PerkinElmer (PKI +1.5%) are all up, albeit modestly. Cue Health, which had its IPO in September, hit a three-month high today.

For further details see:

As demand surges, at-home COVID test makers rise led by Cue Health and Lucira Health